Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy.
Excess melanocytic nevi have been reported in several groups of immunosuppressed patients, including organ transplant recipients. We report the case of a 16-year-old transplant recipient whose post-transplant melanocytic nevi decreased in size and color after graft rejection and interruption of immunosuppressive therapy. This case may represent a visual example of an effective immunosurveillance system against melanocytic nevi.
Piaserico
Stefano
S
Unit of Dermatology, University of Padua, Padua, Italy. stefano.piaserico@unipd.it
Alaibac
Mauro
M
Fortina
Anna Belloni
AB
Peserico
Andrea
A
D000293:Adolescent; D003116:Color; D046169:Dermoscopy; D006801:Humans; D007157:Immunologic Surveillance / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D008544:Melanocytes / Q000276:immunology; D009365:Neoplasm Regression, Spontaneous / Q000276:immunology*; D009508:Nevus, Pigmented / Q000276:immunology*
D007166:Immunosuppressive Agents